Milk ( DrugBank: Milk )
2 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
98 | Eosinophilic gastrointestinal disease | 1 |
210 | Single Ventricle | 1 |
98. Eosinophilic gastrointestinal disease
Clinical trials : 171 / Drugs : 184 - (DrugBank : 47) / Drug target genes : 42 - Drug target pathways : 141
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02579876 (ClinicalTrials.gov) | October 2015 | 14/10/2015 | Milk Patch for Eosinophilic Esophagitis | A Double, Blind Placebo-controlled, Randomized Trial to Study Efficacy and Safety of the Viaskin Milk for Treating Milk Induced Eosinophilic Esophagitis in Children | Eosinophilic Esophagitis;Milk Allergy | Drug: Viaskin Milk 500 mcg;Drug: Viaskin Placebo | Children's Hospital of Philadelphia | DBV Technologies | Completed | 4 Years | 17 Years | All | 20 | Phase 2 | United States |
210. Single Ventricle
Clinical trials : 49 / Drugs : 53 - (DrugBank : 23) / Drug target genes : 32 - Drug target pathways : 67
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02860702 (ClinicalTrials.gov) | July 2016 | 28/7/2016 | Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology | A Randomized Controlled Trial to Evaluate Growth Velocity and Clinical Outcomes of Infants With Single Ventricle Physiology Fed an Exclusive Human Milk Diet With Early Nutritional Fortification Following Surgical Repair | Congenital Heart Defect | Other: Human Milk Derived Fortifier;Other: Human/Bovine Milk | The University of Texas Health Science Center at San Antonio | Prolacta Bioscience;Baylor College of Medicine;Children's Hospital Medical Center, Cincinnati;Columbia University;University of Oklahoma;Ann & Robert H Lurie Children's Hospital of Chicago;Cook Children's Medical Center;Children's Hospital of Orange County;University of Texas;University of Florida | Active, not recruiting | N/A | 7 Days | All | 16 | N/A | United States |